Home > Financial Ratios > GUJARAT THEMIS BIOSYN

GUJARAT THEMIS BIOSYN
Core EBITDA Growth

    Back to All Ratios
GUJARAT THEMIS BIOSYN is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

GUJARAT THEMIS BIOSYN Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) -14.233.5929.1842.4329.97

What is the latest Core EBITDA Growth ratio of GUJARAT THEMIS BIOSYN ?

The latest Core EBITDA Growth ratio of GUJARAT THEMIS BIOSYN is -14.23 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar2025-14.23
Mar20243.59
Mar202329.18
Mar202242.43
Mar202129.97

How is Core EBITDA Growth of GUJARAT THEMIS BIOSYN Trending?

Years Core EBITDA Growth % Change
Mar2025 -14.23
Negative
Mar2024 3.59
-87.70
Mar2023 29.18
-31.23
Mar2022 42.43
41.57
Mar2021 29.97 -

Other Financial Ratios of GUJARAT THEMIS BIOSYN


Compare Core EBITDA Growth ratio of peers of GUJARAT THEMIS BIOSYN

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN ₹2,741.4 Cr -6.4% -18.6% -14.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹406,603.0 Cr -5.6% -2.5% -1.7% Stock Analytics
DIVIS LABORATORIES ₹155,485.0 Cr -2.6% -8.7% 1.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹135,009.0 Cr -7.2% -8% 27.6% Stock Analytics
DR REDDYS LABORATORIES ₹101,628.0 Cr -6.5% -5.4% 3.9% Stock Analytics
CIPLA ₹96,400.8 Cr -4.1% -11.5% -19% Stock Analytics


GUJARAT THEMIS BIOSYN Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GUJARAT THEMIS BIOSYN

-6.4%

-18.6%

-14.1%

SENSEX

-1%

-10.9%

-6%


You may also like the below Video Courses